Rhelion Life Sciences Corp. (TRUFF) Financials
TRUFF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 15.4 million | 2.7 million |
| March 31, 2026 | 10.4 million | 2.4 million |
| Dec. 31, 2025 | 13.3 million | 2.6 million |
| Sept. 30, 2025 | 13.7 million | 2.4 million |
TRUFF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -626022 | ? |
| March 31, 2026 | -1.1 million | -140717 |
| Dec. 31, 2025 | -586011 | 254284 |
| Sept. 30, 2025 | -545153 | 31581 |
TRUFF Net Income
No data available :(
TRUFF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 5.7 million | - | 146086 |
| March 31, 2026 | 6.5 million | - | 205556 |
| Dec. 31, 2025 | 7.2 million | - | 219890 |
| Sept. 30, 2025 | 7.7 million | - | 274055 |
TRUFF Shares Outstanding
TRUFF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 2 | 57319 | 1.1 million | 136600 |
| March 31, 2026 | 780543 | 4664 | 831962 | 38700 |
| Dec. 31, 2025 | 2346 | 5951 | 1.1 million | 61665 |
| Sept. 30, 2025 | 1733 | 2059 | 878089 | 47973 |
TRUFF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 131019 | 78387 |
| March 31, 2026 | 627711 | 298859 |
| Dec. 31, 2025 | 921794 | 722985 |
| Sept. 30, 2025 | 541563 | 306509 |
TRUFF
Price: $0.02
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -1.20
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 7.8 million